Dr. Christopher P. Ingelmo, MD

Dr. Ingelmo practices at Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care.

Dr. Ingelmo's NPI, 1659417855, was assigned on January 29, 2007. Dr. Ingelmo graduated from Northwestern University Feinberg Medical School in 2004. Dr. Ingelmo holds Tennessee license 48809.

Dr. Ingelmo's primary practice is Baptist Memorial Hospital-Memphis, at 6019 Walnut Grove Road, Memphis, TN 38120 in Shelby County. The practice phone is (901) 226-5000.

Dr. Ingelmo's primary practice is Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care. Dr. Ingelmo is also affiliated with Baptist Memorial Hospital-DeSoto. The medical group on file is Stern Cardiovascular Foundation. Dmand AI also links Dr. Ingelmo to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ingelmo practices, 7 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Ingelmo's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Ingelmo is licensed in Tennessee.

CMS data shows 10,690 Medicare services from Dr. Ingelmo across 47 procedure codes in 2024, for 2,175 Medicare patients. Medicare paid $515,259 for them.

CMS counts 2,175 Medicare patients who saw Dr. Ingelmo in 2024. The largest group is 75 to 84, with 897 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ingelmo's median patient age at 72, with 51% women.

In 2024, Dr. Ingelmo wrote 6,808 Medicare Part D claims for 1,196 patients. 78% of them were for generic drugs. CMS names the drug for 6,568 of them, across 65 drugs with 11 or more claims each, at $1,386,017 in total drug cost. In 2023, CMS named 6,387 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ingelmo for performance year 2024, reported as part of a group. Dr. Ingelmo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ingelmo as offering telehealth. CMS counts 56 procedures of pacemaker insertion or repair by Dr. Ingelmo, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Ingelmo, published from 2011 to 2012. 2012 was the busiest year, with 2. The most frequent topics are Electrodes, Implanted. Dr. Ingelmo has published most often in J Interv Card Electrophysiol. Dr. Ingelmo's most frequent co-authors are Oussama M. Wazni, MD, David O. Martin, MD and Bryan J. Baranowski.

CMS Open Payments shows 783 general payments to Dr. Ingelmo from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Medical Device Business Services, Inc. paid the most, $19,089.

Dr. Ingelmo graduated from Northwestern University Feinberg Medical School in 2004.